相关实验视频
Updated: Jul 20, 2025
11:42
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
11.7K
在血小板分泌和功能中的VAMP-2, -3,和 -7的互补作用
Smita Joshi1, Kanakanagavalli Shravani Prakhya1, Alexis N Smith1
1Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.
Platelets
|August 7, 2023
概括
血小板分泌依赖于可溶性N-乙基马莱胺敏感附着蛋白受体 (SNARE). VAMP-7在溶酶体释放中发挥作用,但血小板分泌和血液静止在很大程度上不受其缺席的影响.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 血小板分泌是由可溶性N-乙烯胺胺敏感附着蛋白受体 (SNARE) 介导的.
- 囊泡相关膜蛋白 (VAMP) 是关键的v-SNARE,参与颗粒的释放.
- 血小板VAMP的异质性使理解它们在血液静止中的特定作用变得复杂.
研究的目的:
- 研究VAMP-7 (V7) 在血小板分泌和血液静止中的特定作用.
- 定义VAMP-2 (V2),VAMP-3 (V3) 和VAMP-7 (V7) 在释放血小板颗粒中的特定背景功能.
主要方法:
- 对具有VAMP基因 (V2,V3,V7) 全球和血小板特异性缺失的小鼠进行分析.
- 测量从血小板释放货物的动力学.
- 在三种损伤模型中评估血液静止和血栓形成.
主要成果:
- 丢失V7对密度和α颗粒的释放的影响最小,但影响了溶酶体的释放.
- 结合V3和V7或V2,V3和V7的删除导致alpha和lysosomal释放的部分缺陷.
- 在被删除VAMP的小鼠中,没有观察到出血或遮性血栓的显著缺陷,突出显示了VAMP-8的优势.
结论:
- VAMP-7在溶酶体释放中发挥作用,其中VAMP-3部分补偿.
- VAMP-7和VAMP-3有助于阿尔法颗粒的释放.
- 单独或联合删除V2,V3和V7极少影响血小板分泌和血液静止,强调VAMP-8的关键作用.
相关概念视频
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
01:22Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
01:05Introduction to Hemostasis
8.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K
01:16Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K